These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of distinct chemical structures for the development of a methamphetamine vaccine. Moreno AY; Mayorov AV; Janda KD J Am Chem Soc; 2011 May; 133(17):6587-95. PubMed ID: 21473576 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies against haptens. Takatori T; Nagao M; Terazawa K Nihon Hoigaku Zasshi; 1992 Dec; 46(6):449-54. PubMed ID: 1303451 [TBL] [Abstract][Full Text] [Related]
6. A vaccine against methamphetamine attenuates its behavioral effects in mice. Shen XY; Kosten TA; Lopez AY; Kinsey BM; Kosten TR; Orson FM Drug Alcohol Depend; 2013 Apr; 129(1-2):41-8. PubMed ID: 23022610 [TBL] [Abstract][Full Text] [Related]
7. A new strategy for improved nicotine vaccines using conformationally constrained haptens. Meijler MM; Matsushita M; Altobell LJ; Wirsching P; Janda KD J Am Chem Soc; 2003 Jun; 125(24):7164-5. PubMed ID: 12797775 [TBL] [Abstract][Full Text] [Related]
8. Optimization of a methamphetamine conjugate vaccine for antibody production in mice. Stevens MW; Gunnell MG; Tawney R; Owens SM Int Immunopharmacol; 2016 Jun; 35():137-141. PubMed ID: 27039212 [TBL] [Abstract][Full Text] [Related]
9. Probing the effects of hapten stability on cocaine vaccine immunogenicity. Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436 [TBL] [Abstract][Full Text] [Related]
10. Induction of methamphetamine-specific antibody using biodegradable carboxymethyl-chitin. Tokura S; Hasegawa O; Nishimura S; Nishi N; Takatori T Anal Biochem; 1987 Feb; 161(1):117-22. PubMed ID: 3578777 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines. Carroll FI; Blough BE; Pidaparthi RR; Abraham P; Gong PK; Deng L; Huang X; Gunnell M; Lay JO; Peterson EC; Owens SM J Med Chem; 2011 Jul; 54(14):5221-8. PubMed ID: 21682289 [TBL] [Abstract][Full Text] [Related]
12. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination. Wenthur CJ; Cai X; Ellis BA; Janda KD Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828 [TBL] [Abstract][Full Text] [Related]
13. Vaccine development against methamphetamine drug addiction. Hossain MK; Hassanzadeganroudsari M; Nurgali K; Apostolopoulos V Expert Rev Vaccines; 2020 Dec; 19(12):1105-1114. PubMed ID: 33251859 [TBL] [Abstract][Full Text] [Related]
14. Vaccines against stimulants: cocaine and MA. Kosten T; Domingo C; Orson F; Kinsey B Br J Clin Pharmacol; 2014 Feb; 77(2):368-74. PubMed ID: 23509915 [TBL] [Abstract][Full Text] [Related]
15. Hapten optimization for cocaine vaccine with improved cocaine recognition. Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171 [TBL] [Abstract][Full Text] [Related]
16. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density. Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389 [TBL] [Abstract][Full Text] [Related]